NCT07231250 2025-11-19Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaSun Yat-sen UniversityPhase 2 Not yet recruiting40 enrolled
NCT06481826 2024-07-01Glofitamab in Chinese Patients With R/R DLBCLPeking Union Medical College HospitalRecruiting20 enrolled